Brent James, the quality and patient safety expert, sees excess mortality from lack of care for life-threatening conditions other than COVID-19. Watch James' interview in this part one of three video series.
Brent James, M.D., M.Stat., doesn’t want to be misunderstood. COVID-19 is a big deal. But…
“How do I nuance this? Covid is a very important disease, it has had a major impact,” James said in video interview with Managed Healthcare Executive® this week. “But not to the extent that some of the news media and some of our political leaders have pumped it. This is well within our scale as it turns out.”
James, an international leader in quality improvement and patient safety who became well known for his work at Intermountain Healthcare in Salt Lake City, said the initial reaction was understandable: “People are trying to make decisions in the face of poor data.”
And he noted that some health systems were hit hard by COVID-19, citing as example Northwell Health, the 23-hospital system in Long Island and New York City. James said he has been working with Michael Dowling, the Northwell president and CEO, and that Dowling did, indeed, have a “true crisis.”
But James, who is a clinical research professor at Stanford but still lives in Utah, says there is “night and day” difference between what happened at Northwell and where he lives. He said he had been told about a steep drop in the number of stroke and heart attack patients being seen in the emergency departments of Utah hospitals.
“It is not because those diseases aren’t happening. They most definitely are still happening. No question about it. The difference is that [patients] aren’t coming into system.”
James said a certain proportion of the current excess mortality in the country — he said he wasn’t sure how much — is coming indirectly from Covid-19 and the lack of care for life-threatening illnesses.
“Did Covid cause it [indirectly]? Yes. But it is because people didn’t come in for care for treatable disease that are life threatening. Like heart attacks, like strokes.“
James talked about the need to take a balanced approach to the outbreak.
“I am trained not just as a statistician. I am also a surgeon. I was trained in surgical triage; as a statistician I would call it proportional hazards. You realize it is never just one thing. It is a whole array of things. You are trying to balance this new challenge against the array of other things that human beings continue to face.”
“Some people have been ‘professionally disappointing’ in terms of taking a careful, thoughtful balanced approach,” said James, without naming anyone. “They tend to be screamers, their hair caught on fire. The news media, to some degree, that is their business.”
James said he expects monoclonal antibodies to lead to successful treatment and effective vaccines, although the traditional, protein-based vaccines will take longer.
“We’ll get on top of it. When we get on top of it, we’ll be looking back. I am really interested in seeing how fast it drops out of consciousness, how fast we get back to normal life after it is gone.”
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More